Technologies

Indications

Stem Cell Technology

High-quality human umbilical cord-derived mesenchymal stem cells (hUC-MSC), produced from our proprietary technology platforms, possess superior therapeutic potential to regulate immune system, inhibit inflammation and promote the recovery of injured and diseased tissues. Our hUC-MSC drug delivery system utilizes the precise targeting ability of hUC-MSC to increase the delivery efficiency while reduce the off-target side effects of systemically administrated medicines.

We have applied our proprietary stem cell technology platform to build what we believe is the most advanced stem cell-based product portfolio in the industry. Our technology platform has the potential to address multiple incurable diseases with significant unmet market needs.

About Us                                                                                  Scientific Publications

Technology and Product                                                  Intellectual Property

Core Technologies

Product Pipeline                                                                   Partnerships

Rheumatoid Arthritis

Crohn's Disease                                                                     Mission

Advanced Cancer

                                                                                                      GMP

                                                                                                      Contact Us

 

                                                                                                                                                                                                      © 2019 Baylx,Inc. All rights reserved.